Ernexa Therapeutics (ERNA) Receivables - Other (2018 - 2026)
Ernexa Therapeutics' Receivables - Other came in at $83,000 for Q2 2026, down 46.1% from $154,000 a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Receivables - Other (2018 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics' Receivables - Other was $95,000, down 78.3% from FY2024.
- Receivables - Other carries a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- Going back by year, Receivables - Other was $437,000 in FY2024 (+2.8%), $425,000 in FY2023 (-55.3%), $951,000 in FY2022 (+39.0%) and $684,000 in FY2021 (+510.7%).
- The Q2 2026 figure represents the lowest quarterly Receivables - Other in data going back to Q4 2018.
- Year-over-year, Receivables - Other has declined for six consecutive quarters, with an average decline of 44.5% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q4 2021 (growth of 510.7%), and the weakest in Q3 2024 (a decline of 89.5%).
- Business Quant data shows ERNA's Receivables - Other at $95,000 (Q1 2026), $95,000 (Q4 2025) and $153,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ernexa Therapeutics | 3.74 Mn | 3.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Sep 30, 2024 | 187,000.00 |
| Jun 30, 2024 | 228,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | 425,000.00 |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 647,000.00 |
| Dec 31, 2022 | 951,000.00 |
| Sep 30, 2022 | 926,000.00 |
| Jun 30, 2022 | 694,000.00 |
| Mar 31, 2022 | 835,000.00 |
| Dec 31, 2021 | 684,000.00 |
| Dec 31, 2020 | 112,000.00 |
API Access
Ernexa Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();